Quốc gia: Úc
Ngôn ngữ: Tiếng Anh
Nguồn: Department of Health (Therapeutic Goods Administration)
olmesartan medoxomil, Quantity: 40 mg; amlodipine besilate, Quantity: 6.95 mg; hydrochlorothiazide, Quantity: 12.5 mg
Accord Healthcare Pty Ltd
Tablet, film coated
Excipient Ingredients: lactose monohydrate; isopropyl alcohol; pregelatinised maize starch; povidone; silicified microcrystalline cellulose; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350
Oral
30 Tablets, 10 tablets
(S4) Prescription Only Medicine
OLMESARTAN/ AMLODIPINE HCT Intas is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination. This fixed dose combination is not indicated for initial therapy.
Visual Identification: Light yellow, round, bevel-edged, film-coated tablets debossed with OC2 on one side and plain on other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Registered
2019-11-21